Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTOCLO in Radiation-Induced Brachial Plexopathy
NCT01291433Phase 3
Key facts
- Status
- Completed
- Start
- Mar 2011
- Primary completion
- May 2017
- Countries
- 1
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Conditions
- radiation-induced brachial plexopathy (RIBP)
01
Overview
Phase 3, randomised, triple-blind trial of pentoxifylline, tocopherol and clodronate in radiation-induced brachial plexopathy (RIBP), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Subjective Objective Medical management Analytic at 18 months. Started Mar 2011; status: completed.
02
Design
- Study design
- RandomizedTriple-blind
03
Who it enrols
Cancer survivors in remission with partial radiation-induced brachial plexopathy confirmed by EMG, occurring more than 6 months after radiotherapy.
04
Endpoints
Primary
Subjective Objective Medical management Analytic
Beyond the preview
Go deeper on NCT01291433.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291433.